Skip to content

Aquacel Ag Surgical in breast cancer study

Aquacel Ag Surgical in breast cancer study - Aquacel Ag Surgical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38445
Enrollment
212
Registered
2013-03-27
Start date
2013-03-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound infections

Interventions

The use of Aquacel Ag Surgical instead of a gauze and tape

Sponsors

Sint Franciscus Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women diagnosed with breast cancer who will undergo breast surgery (ablative therapy or breast conserving therapy)

Exclusion criteria

Exclusion criteria: -local inflammation or ulceration of the breast -use of antibiotics 2 weeks prior to surgery -prior breast surgery past 3 months -allergy for Aquacel Ag Surgical -the inability of reading/understanding not enabling to give informed consent or to fill out questionnaires

Design outcomes

Primary

MeasureTime frame
The hypothesis is that Aquacel Ag Surgical will result in a lower rate of postoperative wound infections because of the silver coating.

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)